ClinVar Miner

Submissions for variant NM_000393.5(COL5A2):c.3178C>T (p.Arg1060Trp)

gnomAD frequency: 0.00010  dbSNP: rs374549843
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000197533 SCV000249977 uncertain significance not provided 2024-04-15 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function
Illumina Laboratory Services, Illumina RCV000294359 SCV000425628 uncertain significance Ehlers-Danlos syndrome type 7A 2016-06-14 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002229091 SCV000631593 likely benign Ehlers-Danlos syndrome, classic type, 1 2023-10-18 criteria provided, single submitter clinical testing
Ambry Genetics RCV002315571 SCV000738690 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2024-06-21 criteria provided, single submitter clinical testing The p.R1060W variant (also known as c.3178C>T), located in coding exon 45 of the COL5A2 gene, results from a C to T substitution at nucleotide position 3178. The arginine at codon 1060 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV001197291 SCV001367941 uncertain significance Ehlers-Danlos syndrome, classic type, 2 2019-03-01 criteria provided, single submitter clinical testing This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3.
Mayo Clinic Laboratories, Mayo Clinic RCV000197533 SCV001714076 uncertain significance not provided 2019-09-10 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV001197291 SCV002779720 uncertain significance Ehlers-Danlos syndrome, classic type, 2 2021-11-12 criteria provided, single submitter clinical testing
Clinical Genetics Laboratory, Skane University Hospital Lund RCV000197533 SCV005196629 uncertain significance not provided 2022-05-27 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.